The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Chimeric Antibody-Global Market Insights and Sales Trends 2025
Synopsis
Chimeric antibody is the first genetically engineered antibody to be produced successfully. It is made by splicing the V region gene of mouse antibody and the C region gene of human antibody into chimeric gene, and then inserting the vector, transfecting the antibody molecule expressed in myeloma tissue. Because it reduces the murine component, it reduces the adverse reactions caused by murine antibody and helps to improve the curative effect.
The global Chimeric Antibody market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Chimeric Antibody in various end use industries. The expanding demands from the Hospital, Scientific Research and Others,, are propelling Chimeric Antibody market. IgG, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the IgM segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Chimeric Antibody market, driven by demand from China, the second largest economy with some signs of stabilising, the Chimeric Antibody market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Chimeric Antibody, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Chimeric Antibody market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Chimeric Antibody market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Chimeric Antibody sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Chimeric Antibody covered in this report include Creative-Biolabs, Biotem and OmniAb Technology, etc.
The global Chimeric Antibody market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Creative-Biolabs
Biotem
OmniAb Technology
Global Chimeric Antibody market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Chimeric Antibody market, Segment by Type:
IgG
IgM
IgA
Others
Global Chimeric Antibody market, by Application
Hospital
Scientific Research
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Chimeric Antibody companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Chimeric antibody is the first genetically engineered antibody to be produced successfully. It is made by splicing the V region gene of mouse antibody and the C region gene of human antibody into chimeric gene, and then inserting the vector, transfecting the antibody molecule expressed in myeloma tissue. Because it reduces the murine component, it reduces the adverse reactions caused by murine antibody and helps to improve the curative effect.
The global Chimeric Antibody market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Chimeric Antibody in various end use industries. The expanding demands from the Hospital, Scientific Research and Others,, are propelling Chimeric Antibody market. IgG, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the IgM segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Chimeric Antibody market, driven by demand from China, the second largest economy with some signs of stabilising, the Chimeric Antibody market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Chimeric Antibody, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Chimeric Antibody market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Chimeric Antibody market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Chimeric Antibody sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Chimeric Antibody covered in this report include Creative-Biolabs, Biotem and OmniAb Technology, etc.
The global Chimeric Antibody market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Creative-Biolabs
Biotem
OmniAb Technology
Global Chimeric Antibody market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Chimeric Antibody market, Segment by Type:
IgG
IgM
IgA
Others
Global Chimeric Antibody market, by Application
Hospital
Scientific Research
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Chimeric Antibody companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Chimeric Antibody
1.1 Chimeric Antibody Market Overview
1.1.1 Chimeric Antibody Product Scope
1.1.2 Chimeric Antibody Market Status and Outlook
1.2 Global Chimeric Antibody Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Chimeric Antibody Market Size by Region (2018-2029)
1.4 Global Chimeric Antibody Historic Market Size by Region (2018-2023)
1.5 Global Chimeric Antibody Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Chimeric Antibody Market Size (2018-2029)
1.6.1 North America Chimeric Antibody Market Size (2018-2029)
1.6.2 Europe Chimeric Antibody Market Size (2018-2029)
1.6.3 Asia-Pacific Chimeric Antibody Market Size (2018-2029)
1.6.4 Latin America Chimeric Antibody Market Size (2018-2029)
1.6.5 Middle East & Africa Chimeric Antibody Market Size (2018-2029)
2 Chimeric Antibody Market by Type
2.1 Introduction
2.1.1 IgG
2.1.2 IgM
2.1.3 IgA
2.1.4 Others
2.2 Global Chimeric Antibody Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Chimeric Antibody Historic Market Size by Type (2018-2023)
2.2.2 Global Chimeric Antibody Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Chimeric Antibody Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Chimeric Antibody Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Chimeric Antibody Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Chimeric Antibody Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Chimeric Antibody Revenue Breakdown by Type (2018-2029)
3 Chimeric Antibody Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Scientific Research
3.1.3 Others
3.2 Global Chimeric Antibody Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Chimeric Antibody Historic Market Size by Application (2018-2023)
3.2.2 Global Chimeric Antibody Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Chimeric Antibody Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Chimeric Antibody Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Chimeric Antibody Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Chimeric Antibody Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Chimeric Antibody Revenue Breakdown by Application (2018-2029)
4 Chimeric Antibody Competition Analysis by Players
4.1 Global Chimeric Antibody Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Chimeric Antibody as of 2022)
4.3 Date of Key Players Enter into Chimeric Antibody Market
4.4 Global Top Players Chimeric Antibody Headquarters and Area Served
4.5 Key Players Chimeric Antibody Product Solution and Service
4.6 Competitive Status
4.6.1 Chimeric Antibody Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Creative-Biolabs
5.1.1 Creative-Biolabs Profile
5.1.2 Creative-Biolabs Main Business
5.1.3 Creative-Biolabs Chimeric Antibody Products, Services and Solutions
5.1.4 Creative-Biolabs Chimeric Antibody Revenue (US$ Million) & (2018-2023)
5.1.5 Creative-Biolabs Recent Developments
5.2 Biotem
5.2.1 Biotem Profile
5.2.2 Biotem Main Business
5.2.3 Biotem Chimeric Antibody Products, Services and Solutions
5.2.4 Biotem Chimeric Antibody Revenue (US$ Million) & (2018-2023)
5.2.5 Biotem Recent Developments
5.3 OmniAb Technology
5.3.1 OmniAb Technology Profile
5.3.2 OmniAb Technology Main Business
5.3.3 OmniAb Technology Chimeric Antibody Products, Services and Solutions
5.3.4 OmniAb Technology Chimeric Antibody Revenue (US$ Million) & (2018-2023)
5.3.5 Recent Developments
6 North America
6.1 North America Chimeric Antibody Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Chimeric Antibody Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Chimeric Antibody Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Chimeric Antibody Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Chimeric Antibody Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Chimeric Antibody Market Dynamics
11.1 Chimeric Antibody Industry Trends
11.2 Chimeric Antibody Market Drivers
11.3 Chimeric Antibody Market Challenges
11.4 Chimeric Antibody Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
